1. Vii V. Healthcare, ViiV. Healthcare Announces First Global Regulatory Approval of CABENUVA; the First Complete, Long-acting, Regimen for the Treatment of HIV., 2020 (accessed August 17, 2022) https://viivhealthcare.com/hiv-news-and-media/news/press-releases/2020/ march /viiv-healthcare-announces-first-global-regulatory-approval-of-ca/.
2. U.S. Food, Drug Administration, FDA Approves First Extended-release, Injectable Drug Regimen for Adults Living With HIV., 2021 (accessed August 19, 2022) https://www.fda.gov/news-events/press-announcements/fda-approves-first-extended-release-injectable-drug-regimen-adults-living-hiv.
3. European Medicines Agency, Vocabria, 2020 (accessed August 19, 2022) https://www.ema.europa.eu/en/medicines/human/EPAR/vocabria.
4. Cabotegravir.HIV integrase inhibitor, Anti-HIV agent.;Han;Drugs Fut,2015
5. Long-acting injectable cabotegravir for the prevention of HIV infection;Clement;Curr. Opin. HIV AIDS,2020